U.S. Medical Equipment Stock News

NYSE:UHS
NYSE:UHSHealthcare

The Bull Case For Universal Health Services (UHS) Could Change Following Big Q2 Earnings Beat And Buyback Completion - Learn Why

Universal Health Services recently reported past second-quarter 2026 results showing higher sales of US$4,638.01 million and net income of US$358.45 million, and disclosed that between April 1 and June 30, 2026 it repurchased 1,890,000 shares for US$320.3 million. These results also mark the completion of a long-running buyback program totaling about US$6.62 billion and reducing the share count by very large percentage levels, which can meaningfully influence per-share metrics and capital...
NasdaqGM:DAVE
NasdaqGM:DAVEConsumer Finance

Is Dave (DAVE) Cheap As Raised 2026 Outlook And Buyback Refocus Valuation?

Dave (DAVE) moved back into focus after its early August earnings update, which paired higher reported revenue with a dip in quarterly net income, a raised 2026 revenue outlook, and completion of a sizable buyback. See our latest analysis for Dave. The Q2 update and raised 2026 revenue outlook came alongside a sharp reset in Dave’s share price. The stock is down 12.96% on a 1 day basis and 20.67% over 30 days, yet still carries a 44.86% year to date share price return and a 1 year total...
NYSE:GEF
NYSE:GEFPackaging

Should Greif’s Higher Q3 Earnings and Polymer Bolt‑On Focus Prompt Action From GEF Investors?

In the third quarter of 2026, Greif, Inc. reported higher sales of US$1,165.6 million and net income of US$77.8 million, while updating that one long-running repurchase program dating back to 2005 has now reached 5,674,369 shares for US$360.48 million and a newer 2026 authorization saw no buybacks in the latest quarter. Management also confirmed on the recent earnings call that Greif is prioritizing organic growth supported by recurring bolt-on acquisitions in advanced polymer packaging,...